Paul Tudor Jones's NVS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 9,224 shares of Novartis AG (NVS) worth $1.27 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in NVS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 35,000 shares. Largest reduction occurred in Q4 2025, reducing 25,776 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -25,776 | Reduce 73.65% | 9,224 | $137.87 |
| Q3 2025 | +35,000 | New Buy | 35,000 | $128.24 |
| Q2 2024 | -3,875 | Sold Out | 0 | $0.00 |
| Q1 2024 | +3,875 | New Buy | 3,875 | $96.73 |
Paul Tudor Jones's Novartis Investment FAQs
Paul Tudor Jones first purchased Novartis AG (NVS) in Q1 2024, acquiring 3,875 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Novartis AG (NVS) for 4 quarters since Q1 2024.
Paul Tudor Jones's largest addition to Novartis AG (NVS) was in Q3 2025, adding 35,000 shares worth $4.49 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 9,224 shares of Novartis AG (NVS), valued at approximately $1.27 M.
As of the Q4 2025 filing, Novartis AG (NVS) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Novartis AG (NVS) was 35,000 shares, as reported at the end of Q3 2025.